The Inspire ANTI SNORING Implant is really a medical device that’s implanted in to the body for the treating snoring and obstructive anti snoring (OSA) syndrome.
Obstructive Sleep Apnea Syndrome
Obstructive anti snoring syndrome is really a disease caused by relapsing episodes of anti snoring. It is a condition where breathing stops for a lot more than 10 seconds, during which oxygen saturation in the blood is reduced by a lot more than 4%.
OSA syndrome occurs while asleep, when the muscles of upper airways relax, evoking the obstruction of the respiratory tract. This leads to deterioration of blood oxygenation and provokes short unconscious wake-up episodes throughout the night. An unhealthy pattern of sleep places stress on the body, causing increased blood circulation pressure and development of severe diseases. The diseases caused by OSA could be physical, such as for example hypertension, myocardium infarction and stroke. They might also be mental, including depression, chronic fatigue syndrome, loss of memory and concentration.
Before any treatment, a sleep study or perhaps a polysomnography is necessary. The polysomnography calculates the apnea index, that is the frequency of apnea episodes during one hour of sleep and determines the severity of the disease. The apnea index is considered significant if there are more than 20 apnea episodes each hour, regardless of the presence or lack of clinical symptoms.
The gold standard of treatment for OSA syndrome is CPAP-therapy. However, CPAP therapy isn’t for everyone as many folks find it uncomfortable to sleep with the mask on the face and the machine itself could be loud, especially as it commonly sits near the head. Only 25% of patients can use CPAP-therapy for a long period of time.
Therefore, recently Inspire Medical Systems Inc. has think of a very effective solution with the Inspire ANTI SNORING Implant.
How The Inspire ANTI SNORING Implant Works
The Inspire ANTI SNORING Implant is really a battery operated device that promotes electrostimulation of the sublingual nerve. The battery life is approximately 10 years.
The main unit of the device is placed under the skin, on leading right side of the chest and it monitors the phase of breathing. The other electrode is implanted for stimulation of the sublingual nerve, which creates muscle tension. This opens top of the airways and allows the tongue to stand out, and helps keep the airways open while asleep.
As well as the two electrodes, this device also includes a handy small remote switch, that actually turns on these devices before sleep and switches it off once awake. This disables the electrodes from disturbing the processes of communication and eating during the active phase of your day, whenever a person needs physiological narrowing of the larynx and tongue movements for these processes.
The patient may feel light involuntary contractions of the larynx, or tongue movements during initial use of these devices. These movements usually do not cause pain, instead just a minor discomfort. These unpleasant effects disappear following the first few uses of the device.
Generally, the implant ought to be checked 1 or 2 2 times each year. However, based on the situation, an Inspire therapy-trained doctor may consult patients pretty much often.
The Inspire ANTI SNORING Implant is only ideal for:
Patients who are more than 22 years old.
Patients who’ve been diagnosed with moderate or severe obstructive anti snoring syndrome.
Patients having an apnea index in the number of 20 to 65.
Patients who are uncomfortable with using CPAP therapy or did not work.
ufabet Patients with a body mass index of less than 32.
Body mass index (BMI) = weight (kg) / height^2 (m2).
A person with a weight of 80 kg and a height of 170 cm has
BMI = 80kg / (1.7m ^ 2) = 80 / 2.89 = 27.68 kg/ m2
The Inspire Sleep Apnea Implant may potentially replace CPAP therapy as ‘the gold standard’ of treatment for obstructive anti snoring syndrome. A report by Dr. Ryan J. et al. has shown that after implantation of the Inspire ANTI SNORING Implant, snoring is greatly decreased. A share of “no” or “soft” snoring changed from 22% at beginning of the treatment to 88% at 12 months and 91% at two years following the treatment. Also, the apnea index was reduced from 31 to 14. 82% of the patients in the analysis reported a nightly use of this therapy for five years. Therefore, it is evident that this method is highly effective and simple to use!